SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 102.06 |
Enterprise Value ($M) | 10.77 |
Book Value ($M) | 139.56 |
Book Value / Share | 21.69 |
Price / Book | 0.73 |
NCAV ($M) | 95.67 |
NCAV / Share | 14.87 |
Price / NCAV | 1.07 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.88 |
Return on Assets (ROA) | -0.96 |
Return on Equity (ROE) | -1.20 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 6.04 |
Current Ratio | 6.50 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | n/a |
Assets | n/a |
Liabilities | n/a |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | n/a |
Operating Income | -77.74 |
Net Income | n/a |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -60.92 |
Cash from Investing | n/a |
Cash from Financing | 134.87 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | L1 Capital Global Opportunities Master Fund, Ltd. | 0.00 | -100.00 | |
13G/A | Armistice Capital, Llc | 0.83 | -60.21 | |
13G/A | Empery Asset Management, LP | 1.34 | -24.80 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
109,097 | 283,723 | 38.45 | |
208,134 | 559,996 | 37.17 | |
125,016 | 433,180 | 28.86 | |
206,350 | 598,996 | 34.45 | |
(click for more detail) |
Similar Companies | |
---|---|
TIL – Instil Bio, Inc. | TLSA – Tiziana Life Sciences Ltd |
TNFA – TNF Pharmaceuticals, Inc. | TPST – Tempest Therapeutics, Inc. |
TRAW – Traws Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io